Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis

Autor: J.C. van Denderen, B A C Dijkmans, I E van der Horst-Bruinsma, Michael T. Nurmohamed, M van der Paardt, Y M M A de Ryck

Publikováno v: Annals of the Rheumatic Diseases, 64(12), 1761-1764. BMJ Publishing Group
van Denderen, J C, van der Paardt, M, Nurmohamed, M T, de Ryck, Y M, Dijkmans, B A C & van der Horst-Bruinsma, I E 2005, ' Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis ', Annals of the Rheumatic Diseases, vol. 64, no. 12, pp. 1761-1764 . https://doi.org/10.1136/ard.2005.036491

Objective: To assess the efficacy and safety of leflunomide in active ankylosing spondylitis (AS) compared with placebo in a 24 week pilot study. Methods: In a single centre randomised, double blind, placebo controlled study, 45 patients with active

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82d27f99178a1fc4bffff3583b31eb0
https://doi.org/10.1136/ard.2005.036491